Customer

Notice

2024-12-23

[Money Today] Nam Joong-hyuk, CEO of MEPION: "Laparoscopic adhesion prevention film with reduced side effects, expected to generate sales of 10 billion won"

fec7ab96042560947b6a9c95478fa895_1734920568_6532.jpg


"Every year, about 300,000 minimally invasive surgeries such as laparoscopy are performed, but there are many side effects such as adhesions after surgery. If Mephion's anti-adhesion film developed is used, it will be recognized that side effects can be greatly reduced. If only 10% of minimally invasive surgeries use Mephion's 'anti-adhesion film for laparoscopy and minimally invasive surgery,' annual sales of 10 billion won can be expected." 


Nam Joong-hyuk, CEO of Mephion, said in an interview with our newspaper on the 27th, "We have developed an anti-adhesion film for laparoscopic and minimally invasive surgery and are awaiting the results of the final clinical trial," adding, "Our goal is to complete product approval from the Ministry of Food and Drug Safety by the end of this year and launch it on the market."


Recently, laparoscopic surgery, which involves making small holes instead of cutting the abdomen or chest, is on the rise. The incision area is not large, so there are advantages such as small scars and quick recovery, but the abdomen, where internal organs are intricately intertwined, is prone to experiencing 'adhesion', a side effect in which the organs stick together after surgery.

There are anti-adhesion materials in the form of gels and films to prevent such adhesions, but they are not suitable for laparoscopic surgery. When used on the abdomen or chest, gel-type anti-adhesion materials flow down due to gravity. Existing anti-adhesion films are more suitable for open surgery than laparoscopic surgery. In particular, when using existing anti-adhesion films for laparoscopic surgery, special paper is rolled up to prevent the products from sticking together. The rolled films are spread out in a narrow space to prevent them from sticking together and attached to the necessary location.

Mephion's anti-adhesion film is a thin film, but it has moisture resistance that prevents products from sticking to each other. It also does not break even when rolled up or crumpled. It is easy to attach to body tissue. It is made of biocompatible materials so that secondary removal surgery is not required.
 
Representative Nam explained, "You can just crumple up Mephion's anti-adhesion film," and "just fit it into a small hole and unfold it inside. It won't deform because it can withstand moisture for a certain period of time." The process of inserting and attaching the film takes less than a minute.


He continued, "This is the first domestically developed anti-adhesion film that can be used in minimally invasive surgery," and "We started research and development in 2016, secured product technology in 2018, conducted exploratory clinical trials (phase 2) for the abdominal cavity in 2020, and confirmed clinical trials (phase 3) for the abdominal cavity in 2022, and completed all clinical trials this year."


Representative Nam said, "If you attach it incorrectly, you can't remove it, so even experienced medical staff have a hard time with laparoscopic surgery," and "Isn't it very dangerous to insert and remove foreign substances in the body? I wanted to develop a convenient and good product that reduces side effects and prevents adhesion."



fec7ab96042560947b6a9c95478fa895_1734920688_5358.png


He said, "The main users are general hospitals such as public medical institutions and university hospitals," and "We are comprehensively reviewing the matter, thinking that it would be right to sell it through business partnerships with domestic pharmaceutical companies that have built excellent sales capabilities."

We are also preparing for CE (European sales) certification to enter overseas markets. CEO Nam said, “We have gained confidence and assurance in the product through the clinical process, including positive feedback from medical staff,” and “This is the point where 10 years of research and effort are bearing fruit.”
 

He added, "Mephion is an abbreviation for 'Medical Pioneer' and will continue to introduce innovative products without fear of change and challenges," and "I would like to express my gratitude to the employees who have been with us even in difficult situations."


Copyright © Money Today, 'Real-time news where you can see money'. Unauthorized reproduction and redistribution, use of AI learning prohibited>